The nation of Zimbabwe has declined a significant American healthcare agreement worth 367 million US dollars (£272m) spanning five years due to Washington's demand for confidential information.
This rejection came to light after a internal memorandum dated December was leaked, indicating that President Emmerson Mnangagwa deemed the agreement was "lopsided".
A government representative has since clarified that the US was requesting health data for research and profit while was unwilling to share the benefits from future treatments.
"We are forced to start the challenging and unfortunate task of winding down our support in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy said the US had donated more than $1.9bn as health assistance to Zimbabwe over the last two decades.
A medical body in Zimbabwe has appealed for further talks to find a agreement agreeable to all parties so the nation's vital HIV treatment initiative can be sustained.
Broader Implications
This development comes after a similar situation in Kenya, where a court suspended a related health funding agreement after legal challenges were raised about the security of Kenyans' medical information.
Since resuming office last year, US President Donald Trump has slashed foreign aid and shut down the key foreign aid agency.
The agency had overseen assistance for the US government, but Trump argued its spending was "inefficient" and his government was seeking government-to-government agreements to enhance openness and accountability.
Based on statements, 16 African countries have so far agreed to similar agreements, constituting more than $18.3bn in committed funds.
Specifics of the Declined Agreement
This assistance for Zimbabwe would have supported "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We believe this collaboration could have provided significant advantages for the people of Zimbabwe, particularly the 1.2 million presently receiving HIV treatment via US-supported programmes," Tremont commented.
However, government spokesperson Nick Mangwana maintained the proposed deal was "asymmetrical".
"The proposal required Zimbabwe to share its genetic material and health information for a long time, without any equivalent guarantee of benefiting from any scientific breakthroughs – such as new medicines or tests – that could be developed from that shared data," Mangwana explained.
"Put simply, our country would provide the basic resources for scientific discovery without any certainty that the final treatments would be available to our population if a new disease outbreak emerge."
Sovereignty and International Frameworks
He also said that the US's withdrawal from the global health body and its push of one-on-one health agreements were undermining structures previously set up via the international health agency.
The spokesperson gave as an example its Pandemic Benefit-Sharing framework designed to manage potential pandemics.
"This system is designed to guarantee that when a nation contributes its information, the resulting advantages – including vaccines and treatments – are shared equitably, not monopolised solely by those with the funds to develop them."
These objections over the US deal "are not meant as anti-American sentiment," he added.
"We encourage further discussions with our US partners on how future co-operation could be arranged in a way that respects the independence and interests of both nations."
Health Experts Response
A leading public health body expressed it recognised the government's concerns, but suggested that negotiations need to persist given that much of the country's HIV programmes were funded by international support.
"Where specific concerns arise, such as those involving information security or implementation frameworks, these can often be addressed through detailed discussion and mutually agreed protections," the group added.
The halted deal emphasises the ongoing debate between accepting crucial international aid and protecting a country's data in an ever more interconnected world.